34209471|t|Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation.
34209471|a|Resistance to temozolomide (TMZ) is the main cause of death in glioblastoma multiforme (GBM). The use of nanocarriers for drug delivery applications is one of the known approaches to overcome drug resistance. This study aimed to investigate the possible effect of selenium-chitosan nanoparticles loaded with TMZ on the efficacy of TMZ on the expression of MGMT, E2F6, and RELA genes and the rate of apoptosis in the C6 cell line. Selenium nanoparticles (SNPs) were loaded with TMZ and then they were coated by Eudragit  RS100 (Eud) and chitosan (CS) to prepare Se@TMZ/Eud-Cs. Physicochemical properties were determined by scanning electron microscope (SEM), energy-dispersive X-ray spectroscopy (EDAX), thermal gravimetric analysis (TGA), Fourier-transform infrared spectroscopy (FTIR), and dynamic light scattering (DLS) methods. Se@TMZ/Eud-Cs was evaluated for loading and release of TMZ by spectrophotometric method. Subsequently, SNPs loaded with curcumin (as a fluorophore) were analyzed for in vitro uptake by C6 cells. Cytotoxicity and apoptosis assay were measured by MTT assay and Annexin-PI methods. Finally, real-time PCR was utilized to determine the expression of MGMT, E2F6, and RELA genes. Se@TMZ/Eud-Cs was prepared with an average size of 200 nm as confirmed by the DLS and microscopical methods. Se@TMZ/Eud-Cs presented 82.77 +- 5.30 loading efficiency with slow and pH-sensitive release kinetics. SNPs loaded with curcumin showed a better uptake performance by C6 cells compared with free curcumin (p-value < 0.01). Coated nanoparticles loaded with TMZ showed higher cytotoxicity, apoptosis (p-value < 0.0001), and down-regulation of MGMT, E2F6, and RELA and lower IC50 value (p-value < 0.0001) than free TMZ and control (p-value < 0.0001) groups. Using Cs as a targeting agent in Se@TMZ/Eud-Cs system improved the possibility for targeted drug delivery to C6 cells. This drug delivery system enhanced the apoptosis rate and decreased the expression of genes related to TMZ resistance. In conclusion, Se@TMZ/Eud-Cs may be an option for the enhancement of TMZ efficiency in GBM treatment.
34209471	24	36	Temozolomide	Chemical	MESH:D000077204
34209471	44	61	Eudragit-Chitosan	Chemical	-
34209471	69	77	Selenium	Chemical	MESH:D012643
34209471	116	128	Cytotoxicity	Disease	MESH:D064420
34209471	175	187	temozolomide	Chemical	MESH:D000077204
34209471	189	192	TMZ	Chemical	MESH:D000077204
34209471	215	220	death	Disease	MESH:D003643
34209471	224	247	glioblastoma multiforme	Disease	MESH:D005909
34209471	249	252	GBM	Disease	MESH:D005909
34209471	425	433	selenium	Chemical	MESH:D012643
34209471	434	442	chitosan	Chemical	MESH:D048271
34209471	469	472	TMZ	Chemical	MESH:D000077204
34209471	492	495	TMZ	Chemical	MESH:D000077204
34209471	517	521	MGMT	Gene	4255
34209471	523	527	E2F6	Gene	1876
34209471	533	537	RELA	Gene	5970
34209471	577	579	C6	CellLine	CVCL:0194
34209471	591	599	Selenium	Chemical	MESH:D012643
34209471	638	641	TMZ	Chemical	MESH:D000077204
34209471	671	686	Eudragit  RS100	Chemical	MESH:C050528
34209471	688	691	Eud	Chemical	MESH:C050528
34209471	697	705	chitosan	Chemical	MESH:D048271
34209471	707	709	CS	Chemical	MESH:D048271
34209471	722	728	Se@TMZ	Chemical	-
34209471	729	735	Eud-Cs	Chemical	-
34209471	992	998	Se@TMZ	Chemical	-
34209471	999	1005	Eud-Cs	Chemical	-
34209471	1047	1050	TMZ	Chemical	MESH:D000077204
34209471	1112	1120	curcumin	Chemical	MESH:D003474
34209471	1177	1179	C6	CellLine	CVCL:0194
34209471	1187	1199	Cytotoxicity	Disease	MESH:D064420
34209471	1237	1240	MTT	Chemical	MESH:C070243
34209471	1338	1342	MGMT	Gene	4255
34209471	1344	1348	E2F6	Gene	1876
34209471	1354	1358	RELA	Gene	5970
34209471	1366	1372	Se@TMZ	Chemical	-
34209471	1373	1379	Eud-Cs	Chemical	-
34209471	1475	1481	Se@TMZ	Chemical	-
34209471	1482	1488	Eud-Cs	Chemical	-
34209471	1594	1602	curcumin	Chemical	MESH:D003474
34209471	1641	1643	C6	CellLine	CVCL:0194
34209471	1669	1677	curcumin	Chemical	MESH:D003474
34209471	1729	1732	TMZ	Chemical	MESH:D000077204
34209471	1747	1759	cytotoxicity	Disease	MESH:D064420
34209471	1814	1818	MGMT	Gene	4255
34209471	1820	1824	E2F6	Gene	1876
34209471	1830	1834	RELA	Gene	5970
34209471	1885	1888	TMZ	Chemical	MESH:D000077204
34209471	1934	1936	Cs	Chemical	MESH:D002586
34209471	1961	1967	Se@TMZ	Chemical	-
34209471	1968	1974	Eud-Cs	Chemical	-
34209471	2037	2039	C6	CellLine	CVCL:0194
34209471	2150	2153	TMZ	Chemical	MESH:D000077204
34209471	2181	2187	Se@TMZ	Chemical	-
34209471	2188	2194	Eud-Cs	Chemical	-
34209471	2235	2238	TMZ	Chemical	MESH:D000077204
34209471	2253	2256	GBM	Disease	MESH:D005909
34209471	Negative_Correlation	MESH:D000077204	MESH:D012643
34209471	Positive_Correlation	MESH:D000077204	MESH:D064420
34209471	Association	MESH:D000077204	MESH:D048271
34209471	Positive_Correlation	MESH:D000077204	5970
34209471	Association	MESH:C050528	MESH:D012643
34209471	Negative_Correlation	MESH:D000077204	4255
34209471	Negative_Correlation	MESH:D000077204	MESH:D005909
34209471	Association	MESH:D012643	MESH:D048271
34209471	Positive_Correlation	MESH:D000077204	1876

